NEW YORK (AP) — Pfizer Inc. said Wednesday the Australian Competition and Consumer Commission approved the company’s $68 billion buyout of rival Wyeth. Pfizer will divest certain animal health assets in Australia, the New York-based company said. The buyout deal still needs regulatory approval in the U.S. and Canada. The deal received Chinese regulatory approval Tuesday. The companies expect the deal to close early in the fourth quarter.
